BCL2 and adult T-cell leukemia/lymphoma: Moreover, Kunami et al. explore the therapeutic efficacy of combining a BCL-2 family inhibitor with either bortezomib (a proteasome inhibitor) or SAHA (Suberoylanilide Hydroxamic Acid (Vorinostat)) in ATLL associated with HTLV-1 infection [57].